... Referencias
Early HIV Diagnosis and Treatment Important for Better Long-Term Health Outcomes — National Institutes of Health
Los síntomas del VIH — HIV.gov
Acute and Early HIV Infection: Clinical Manifestations and Diagnosis — Wolters Kluwer UpToDate
Síntomas iniciales del VIH: ¿qué son? ...
Dolor de garganta y VIH: ¿es un síntoma temprano?
... Referencias
Early HIV Diagnosis and Treatment Important for Better Long-Term Health Outcomes — National Institutes of Health
Los síntomas del VIH — HIV.gov
Acute and Early HIV Infection: Clinical Manifestations and Diagnosis — Wolters Kluwer UpToDate
Síntomas iniciales del VIH: ¿qué son? ...
... HIV/AIDS: The Need for an Integrated Response — AIDS
The Characteristics and HIV-Related Outcomes of People Living With Co-occurring HIV and Mental Health Conditions in the United States: A Systematic Review of Literature from 2016 to 2021 — AIDS and Behavior
Associations Between Felt Stigma, Social Support, and Anxiety and Depression Symptoms in Adults ...
¿Se puede saber si alguien tiene VIH solo con verlo? Desmintiendo mitos
... HIV/AIDS: The Need for an Integrated Response — AIDS
The Characteristics and HIV-Related Outcomes of People Living With Co-occurring HIV and Mental Health Conditions in the United States: A Systematic Review of Literature from 2016 to 2021 — AIDS and Behavior
Associations Between Felt Stigma, Social Support, and Anxiety and Depression Symptoms in Adults ...
... of HIV in Latin America and the Caribbean — Current HIV/AIDS Reports
...
... of HIV-2 Infection: Available Drugs, Resistance Pathways, and Promising New Compounds — International Journal of Molecular Sciences
HIV Vaccines — HIV.gov
Trends in HIV-2 Diagnoses and Use of the HIV-1/HIV-2 Differentiation Test — United States, 2010-2017 — Morbidity and Mortality Weekly Report
Treatment of HIV-2 Infection — Wolters Kluwer UpToDate ...
VIH-1 frente a VIH-2: ¿Cuáles son las diferencias y puede tener ambas?
... of HIV-2 Infection: Available Drugs, Resistance Pathways, and Promising New Compounds — International Journal of Molecular Sciences
HIV Vaccines — HIV.gov
Trends in HIV-2 Diagnoses and Use of the HIV-1/HIV-2 Differentiation Test — United States, 2010-2017 — Morbidity and Mortality Weekly Report
Treatment of HIV-2 Infection — Wolters Kluwer UpToDate ...
... Department of Veterans Affairs
Expert Consensus Statement on the Science of HIV in the Context of Criminal Law — Journal of the International AIDS Society
VIH PrEP y PEP — MedlinePlus
HIV Infection: Risk Factors and Prevention Strategies — Wolters Kluwer UpToDate
HIV Viral Load — Cleveland Clinic
¿Cómo se transmite el VIH? ...
... Preventive Services Task Force
Prevención de la transmisión perinatal del VIH durante el embarazo y parto — HIVinfo.NIH.gov
Local Data: United States — AIDSVu
Inyección de lenacapavir — MedlinePlus
Hoja informativa — ONUSIDA
Acute and Early HIV Infection: Clinical Manifestations and Diagnosis — Wolters Kluwer UpToDate
Fungal Diseases and HIV/AIDs — ...
¿Qué es el virus de la inmunodeficiencia humana? Qué hace y más
... Preventive Services Task Force
Prevención de la transmisión perinatal del VIH durante el embarazo y parto — HIVinfo.NIH.gov
Local Data: United States — AIDSVu
Inyección de lenacapavir — MedlinePlus
Hoja informativa — ONUSIDA
Acute and Early HIV Infection: Clinical Manifestations and Diagnosis — Wolters Kluwer UpToDate
Fungal Diseases and HIV/AIDs — ...
... You Have Sex With That You Have HIV — Aidsmap
PrEP (Pre-Exposure Prophylaxis) — Centers for Disease Control and Prevention
Cabenuva: Dosing and Administration Guide — ViiV Healthcare
Male (External) Condom Use — Centers for Disease Control and Prevention ...
Cómo encarar los vínculos románticos con VIH
... You Have Sex With That You Have HIV — Aidsmap
PrEP (Pre-Exposure Prophylaxis) — Centers for Disease Control and Prevention
Cabenuva: Dosing and Administration Guide — ViiV Healthcare
Male (External) Condom Use — Centers for Disease Control and Prevention ...
... Food and Drug Administration
FDA Approves First Twice-a-Year HIV Prevention Shot, Yeztugo — Drugs.com
Yeztugo Lenacapavir Is Now the First and Only FDA Approved HIV Prevention Option Offering 6 Months of Protection — Gilead
Drug Database: Cabotegravir — Clinicalinfo.HIV.gov
VIH/sida — Mayo Clinic
Barriers to HIV Medication Adherence as a Function ...
Cómo funcionan los medicamentos inyectables para tratar y prevenir el VIH
... Food and Drug Administration
FDA Approves First Twice-a-Year HIV Prevention Shot, Yeztugo — Drugs.com
Yeztugo Lenacapavir Is Now the First and Only FDA Approved HIV Prevention Option Offering 6 Months of Protection — Gilead
Drug Database: Cabotegravir — Clinicalinfo.HIV.gov
VIH/sida — Mayo Clinic
Barriers to HIV Medication Adherence as a Function ...
... References
HIV Infection: Risk Factors and Prevention Strategies — Wolters Kluwer UpToDate
The Impact of HIV on Hispanic/Latino People in the United States — KFF
HIV Among Latinos — League of United Latin American Citizens
Putting a Number on It: The Risk From an Exposure to HIV — Stanford Medicine
Estimated HIV Risk Per Exposure — Aidsmap
...
Probabilidad de contagio de VIH en una sola exposición: todo lo que necesita saber
... References
HIV Infection: Risk Factors and Prevention Strategies — Wolters Kluwer UpToDate
The Impact of HIV on Hispanic/Latino People in the United States — KFF
HIV Among Latinos — League of United Latin American Citizens
Putting a Number on It: The Risk From an Exposure to HIV — Stanford Medicine
Estimated HIV Risk Per Exposure — Aidsmap
...
únete
Tus opciones de privacidad
